Discovering old motorcycles/ Por 455886 Crowley, R. E.

Die design fundamentals Por 335574 Paquin, J. R., Crowley, R. E.

James Joyce's Unpublished Letters [online resource] Por Van Hulle, D, Spoo, R, Groden, M, Dettmar, K, Crowley, R, Brockman, WS, Batinić, J, Alonso, S

Androgenemic Phenotype Predicts Metabolic Disease and Androgen Burden in Polycystic Ovary Syndrome Por O'Reilly, M, Taylor, A, Crabtree, N, Crowley, R, Hughes, B, Stewart, P, Tomlinson, J, Arlt, W

SFRP2 is associated with increased adiposity and VEGF expression. Por Crowley, R, O'Reilly, M, Bujalska, I, Hassan-Smith, Z, Hazlehurst, J, Foucault, D, Stewart, P, Tomlinson, J

Hyperandrogenemia predicts metabolic phenotype in polycystic ovary syndrome: the utility of serum androstenedione. Por O'Reilly, M, Taylor, A, Crabtree, N, Hughes, B, Capper, F, Crowley, R, Stewart, P, Tomlinson, J, Arlt, W

Longitudinal changes in glucocorticoid metabolism are associated with later development of adverse metabolic phenotype. Por Crowley, R, Hughes, B, Gray, J, McCarthy, T, Hughes, S, Shackleton, C, Crabtree, N, Nightingale, P, Stewart, P, Tomlinson, J

Preparing accessible and understandable clinical research participant information leaflets and consent forms: a set of guidelines from an expert consensus conference Por Coleman, E, O'Sullivan, L, Crowley, R, Hanbidge, M, Driver, S, Kroll, T, Kelly, A, Nichol, A, McCarthy, O, Sukumar, P, Doran, P

Increased central adiposity and decreased subcutaneous adipose tissue 11β‐hydroxysteroid dehydrogenase type 1 are associated with deterioration in glucose tolerance—A longitudinal... Por Crowley, R, Woods, C, Hughes, B, Gray, J, McCarthy, T, Taylor, A, Gathercole, L, Shackleton, C, Crabtree, N, Arlt, W, Stewart, P, Tomlinson, J

Advanced non-alcoholic fatty liver disease and adipose tissue fibrosis in patients with Alstrom syndrome. Por Gathercole, L, Hazlehurst, J, Armstrong, M, Crowley, R, Boocock, S, O'Reilly, M, Round, M, Brown, R, Bolton, S, Cramb, R, Newsome, P, Semple, R, Paisey, R, Tomlinson, J, Geberhiwot, T

Continued Beneficial Effects of Burosumab in Adults with X-Linked Hypophosphatemia: Results from a 24-Week Treatment Continuation Period After a 24-Week Double-Blind Placebo-Contro... Por Portale, A, Carpenter, T, Brandi, M, Briot, K, Cheong, H, Cohen-Solal, M, Crowley, R, Jan De Beur, S, Eastell, R, Imanishi, Y, Imel, E, Ing, S, Ito, N, Javaid, M, Kamenicky, P, Keen, R, Kubota, T, Lachmann, R, Perwad, F, Pitukcheewanont, P, Ralston, S, Takeuchi, Y, Tanaka, H, Weber, T, Yoo, H, Zhang, L, Theodore-Oklota, C, Mealiffe, M, San Martin, J, Insogna, K